ICTHIC

ICTHIC promotes recent advances in the understanding of the pathogenesis, prevention and treatment of thrombohemorrhagic complications in cancer patients

[Dr Jean Pierre Laroche @Echoraljpangio]

@MarcCarrier1 GREAT Marc

[Tzu-Fei Wang @TzufeiWang]

A grant finale of #ICTHIC2024 🎆Systematic review and meta-analysis by Dr. @MarcCarrier1 et. al identified multiple risk factors for recurrent VTE in patients with cancer-associated thrombosis.

[Marc Carrier @MarcCarrier1]

Dr. @jzbos demonstrated that proteomics can help to predict cancer-associated thrombosis and provide innovative mechanistic insights (through CD200R1/IL-17A axis). Looking forward seeing additional results at the @isth meeting in Bangkok.
@ICTHIC

[Lucy NORRIS @LucyNORTCD]

Great presentation by @SimonNoble at #icthic24 explaining the importance of involving patients at every stage of research. #PPI is sadly neglected in #cancer associated #thrombosis research. Would be great to see patient representatives at the next @icthic?

[Marc Carrier @MarcCarrier1]

Is FXI inhibition the future of the management of cancer-associated thrombosis?

Dr. @MarcelloDiNisio provided an elegant review @ICTHIC
Potentially low risk of bleeding, less drug-drug interactions, less dependence on renal/liver for elimination.
Phase 3 trials on-going! Stay tuned :)

[Marc Carrier @MarcCarrier1]

Dr. @aakonc highlighting that RCTs assessing Immune Checkpoint Inhibitors for patients with cancer do not capture a large majority of VTEs or ATEs (RCTs vs. Cohorts) @ICTHIC meeting👇
#ICTHIC2024

[Tzu-Fei Wang @TzufeiWang]

Dr. Stanworth gave an elegant talk on the challenges in managing patients with thrombocytopenia and cancer-associated thrombosis, RCT is underway and needed! #ICTHIC2024

[Alok Khorana, MD @aakonc]

Closing up day#2 @ICTHIC #ICTHIC24 with the one and only @SimonNoble on pt/public involvement in CAT research

[Alok Khorana, MD @aakonc]

Day 2 of @ICTHIC #ICTHIC24 kicks off with an important overview of #VTE and mortality in heme malignancies by @KSanfilippoMD

[Marc Carrier @MarcCarrier1]

Fantastic 8th Simon Karpatkin Memorial Lecture at @ICTHIC by Prof Agnes Lee. Interesting overview of the management of cancer-associated thrombosis highlighting an exceptional career by Prof Lee. 🏆 🎉

[Alok Khorana, MD @aakonc]

It's not just #VTE, @debsiegal describes the impact of stroke in people with cancer #ICTHIC24 @ICTHIC @icthicmagazine

[ICTHIC @ICTHIC]

Online Registration Ending Soon! 12th ICTHIC Bergamo, Italy, May 17-19, 2024

REGISTER NOW: https://t.co/e6UXzqtgI4

[ICTHIC Magazine @icthicmagazine]

The Abstract submission deadline for the 12th International Conference on Thrombosis and Hemostasis issues in cancer is near!

Send your scientific contributions by March 11, 2024.

Check it out here: https://t.co/fi3PKDVYgQ

@ICTICH #thrombosis #cancer #hemostasis #12ICTHIC

[ICTHIC @ICTHIC]

@aakonc @ClionaKirwan @luistrombo

[ICTHIC Magazine @icthicmagazine]

What are the latest insights on the management of incidental VTE in cancer patients?
@luistrombo will answer this question during our webinar:

"Updates in Cancer-Associated Thrombosis"
October 27, 2022, 18.00 CET

Register here https://t.co/FHZkYdAoUi

#thrombosis #cancer

[ICTHIC @ICTHIC]

Thurs 16 June 1700 CET at https://t.co/XY1Ygx32ay… . 📜 soon in @Hemasphere_EHA. Read now at https://t.co/ZHexIXweUH… .@AnnaFalanga19 @LeaderAvi

[Anna Falanga @AnnaFalanga19]

Happy to chair with @LeaderAvi and present with Chiara @EHA_Hematology GLs on antithrombotic Rx in thrombocytopenic cancer patients

[Anna Falanga @AnnaFalanga19]

Happy to chair with @LeaderAvi and present with Chiara @EHA_Hematology GLs on antithrombotic Rx in thrombocytopenic cancer patients

[Marc Carrier @MarcCarrier1]

Fantastic meeting #icthic2022 with many Ottawa 🇨🇦 colleagues and previous, new and future Italian 🇮🇹 fellows training @OttawaHospital. Fostering new and exciting collaborations for the prevention and management of cancer-associated thrombosis. Arrivederci nel 2024

[Alok Khorana, MD @aakonc]

Stars of @ICTHIC #icthic2022 with our founding Chair Prof Falanga. The future of CAT is 🔥🔥🔥

[Cihan Ay @Cihan_Ay_MD]

What an emotion to be back again to a face-to-face conference with so many colleagues and friends from the thrombosis-haemostasis-cancer community for the 11th ICTHIC in Bergamo. #icthic2022 #icthic22

[Alok Khorana, MD @aakonc]

Dr @KSanfilippoMD presenting risk assessment of heme malignancies @ICTHIC